Overview
Symbiosis is an out-of-hospital healthcare and medical transportation company. The company provides urgent care, ambulance transport, critical-care transportation, event medical services, and telemedicine. It serves patients, hospitals, event operators, public agencies, and healthcare partners. Its operating model centers on clinical, dispatch, transport, and event teams coordinated across multiple care settings. Teams work across emergency medicine, nursing, paramedicine, dispatch, fleet, scheduling, billing, and operations. Projects depend on clear coordination between specialist teams, customer needs, and day-to-day operations. This structure supports consistent delivery across its products and services.
Work here?Claim your company
Simplify's take
What believers are saying
- October 2026 brought three commercial hires targeting APAC, Southern Europe, and the Middle East.
- The 2026 £26 million expansion supports larger clinical and commercial programs.
- Commercial production at the new facility started after Q4 2025 qualification and first batches.
What critics are saying
- A single-product CDMO slip in 2026 could idle the new Stirling expansion.
- Large competitors can undercut Symbiosis on price and win later-stage commercial contracts.
- If sterile capacity stays underfilled through 2027, the £26 million build becomes a cash drain.
What makes Symbiosis unique
- Symbiosis runs FDA- and MHRA-inspected aseptic fill-finish in Stirling, Scotland.
- Its 2025 FPD 50 Flexicon line handles precise Grade A vial filling.
- The QC lab now covers all ICH climatic zones after the 30°C chamber installation.
Help us improve and share your feedback! Did you find this helpful?